Search

everythinglearnresearchcommunity

for

Search:↓

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

Methotrexate improved skin condition in 64% of patients with generalized granuloma annulare.

Compound glycyrrhizin with conventional treatments is effective and safe for promoting hair regrowth in alopecia areata.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

New medications could improve treatment for severe alopecia areata in Australia.

Baricitinib is effective and safe for long-term treatment of severe alopecia areata.

Combining baricitinib with golimumab helped regrow hair in a patient with ankylosing spondylitis and alopecia areata.

Leflunomide and methotrexate are similarly effective for rheumatoid arthritis but have different side effects.

Upadacitinib may effectively treat both alopecia universalis and Crohn's disease.

AI-09 is safe, effective, and reduces wrinkles for up to 6 months.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

Liraglutide with metformin reduces body fat and improves blood sugar control better than metformin and inositol in women with prediabetes.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with fewer side effects.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Acitretin treatment unexpectedly darkened a patient's gray hair.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

Tofacitinib treatment is used for teenagers with alopecia areata.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Bexarotene gel shows promise as a new treatment for alopecia areata.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

The drug Olumiant is now approved to treat severe hair loss from alopecia and can also be used for some hospitalized COVID-19 patients.

Baricitinib improved hair loss and arthritis in a lupus patient.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.